Comparison of mesenchymal stem cells and leukocytes from Large White and Gottingen Minipigs: Clues for stem cell-based immunomodulatory therapies

被引:3
|
作者
Alvarez, Veronica [1 ]
Sanchez-Margallo, Francisco-Miguel [1 ]
Blazquez, Rebeca [1 ]
Tarazona, Raquel [2 ]
Casado, Javier G. [1 ]
机构
[1] Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres 10071, Spain
[2] Univ Extremadura, Dept Physiol, Immunol Unit, Caceres 10071, Spain
关键词
Pig; Mesenchymal stem cells; Leukocytes; Lymphocytes; BONE-MARROW; T-CELLS; NATURAL-KILLER; MODEL; EXPRESSION; OSTEOARTHRITIS; REPAIR; NK;
D O I
10.1016/j.vetimm.2016.08.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mesenchymal stem cells (MSCs) are one of the most promising cell types for human and veterinary use and their therapeutic effect is associated with their immunomodulatory properties. Farm animal models, such as pigs, have become a valuable tool to evaluate the safety and efficacy of adoptively transferred MSCs in the setting of veterinary medicine. In order to evaluate the immunomodulatory effect of stem cell-based therapies in porcine breeds, a deep analysis and comparison of MSCs and leukocyte subsets are absolutely necessary. Here we provide a detailed analysis of bone-marrow derived MSCs and leukocyte subsets from Large White pigs and Gottingen Minipigs. Significant differences were observed between the two pig breeds in terms of T cell subsets that need to be considered for immune monitoring of stem cell-based therapies. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [1] Human Mesenchymal Stem Cells and Their Use in Cell-Based Therapies
    Motaln, Helena
    Schichor, Cristian
    Lah, Tamara T.
    [J]. CANCER, 2010, 116 (11) : 2519 - 2530
  • [2] Umbilical Cord Mesenchymal Stem Cells: The New Gold Standard for Mesenchymal Stem Cell-Based Therapies?
    El Omar, Reine
    Beroud, Jacqueline
    Stoltz, Jean-Francois
    Menu, Patrick
    Velot, Emilie
    Decot, Veronique
    [J]. TISSUE ENGINEERING PART B-REVIEWS, 2014, 20 (05) : 523 - 544
  • [3] The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
    Musial-Wysocka, Aleksandra
    Kot, Marta
    Majka, Marcin
    [J]. CELL TRANSPLANTATION, 2019, 28 (07) : 801 - 812
  • [4] Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies
    Dunn, Celia M.
    Kameishi, Sumako
    Grainger, David W.
    Okano, Teruo
    [J]. ACTA BIOMATERIALIA, 2021, 133 (133) : 114 - 125
  • [5] Imaging mesenchymal stem cell migration and the implications for stem cell-based cancer therapies
    Wang, Hui
    Chen, Xiaoyuan
    [J]. FUTURE ONCOLOGY, 2008, 4 (05) : 623 - 628
  • [6] Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
    Lepperdinger, Guenter
    Brunauer, Regina
    Jamnig, Angelika
    Laschober, Gerhard
    Kassem, Moustapha
    [J]. EXPERIMENTAL GERONTOLOGY, 2008, 43 (11) : 1018 - 1023
  • [7] Potential of Mesenchymal Stem Cell-Based Therapies for Pulmonary Fibrosis
    Guo, Zhihou
    Zhang, Yaping
    Yan, Furong
    [J]. DNA AND CELL BIOLOGY, 2022, 41 (11) : 951 - 965
  • [8] Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies
    Ulrich, Daniela
    Muralitharan, Rikeish
    Gargett, Caroline E.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1387 - 1400
  • [9] INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS (IMSC) AS A POWERFUL CELL SOURCE FOR CELL-BASED THERAPIES
    Kot, Marta
    Ulman, Aleksandra
    Konieczny, Pawel
    Skrzypek, Klaudia
    Majka, Marcin
    [J]. TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 1357 - 1358
  • [10] Immunomodulatory effects of mesenchymal stem cells on leukocytes with emphasis on neutrophils
    Salami, Fatemeh
    Tavassoli, Amin
    Mehrzad, Jalil
    Parham, Abbas
    [J]. IMMUNOBIOLOGY, 2018, 223 (12) : 786 - 791